Ocean Biomedical Stock Market Value
| OCEA Stock | 0.70 0.02 2.78% |
| Symbol | Ocean |
Ocean Biomedical Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Ocean Biomedical. If investors know Ocean will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Ocean Biomedical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (3.00) | Return On Assets (6.82) |
The market value of Ocean Biomedical is measured differently than its book value, which is the value of Ocean that is recorded on the company's balance sheet. Investors also form their own opinion of Ocean Biomedical's value that differs from its market value or its book value, called intrinsic value, which is Ocean Biomedical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Ocean Biomedical's market value can be influenced by many factors that don't directly affect Ocean Biomedical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Ocean Biomedical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Ocean Biomedical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Ocean Biomedical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Ocean Biomedical 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Ocean Biomedical's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Ocean Biomedical.
| 10/26/2024 |
| 11/25/2024 |
If you would invest 0.00 in Ocean Biomedical on October 26, 2024 and sell it all today you would earn a total of 0.00 from holding Ocean Biomedical or generate 0.0% return on investment in Ocean Biomedical over 30 days. Ocean Biomedical is related to or competes with Enveric Biosciences, Hepion Pharmaceuticals, Elevation Oncology, and Zura Bio. Ocean Biomedical is entity of United States More
Ocean Biomedical Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Ocean Biomedical's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Ocean Biomedical upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.12) | |||
| Maximum Drawdown | 28.33 | |||
| Value At Risk | (6.93) | |||
| Potential Upside | 7.46 |
Ocean Biomedical Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Ocean Biomedical's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Ocean Biomedical's standard deviation. In reality, there are many statistical measures that can use Ocean Biomedical historical prices to predict the future Ocean Biomedical's volatility.| Risk Adjusted Performance | (0.07) | |||
| Jensen Alpha | (0.56) | |||
| Total Risk Alpha | (1.32) | |||
| Treynor Ratio | (1.39) |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Ocean Biomedical's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Ocean Biomedical Backtested Returns
Ocean Biomedical maintains Sharpe Ratio (i.e., Efficiency) of -0.0575, which implies the firm had a -0.0575% return per unit of risk over the last 3 months. Ocean Biomedical exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check Ocean Biomedical's Variance of 26.43, coefficient of variation of (1,023), and Risk Adjusted Performance of (0.07) to confirm the risk estimate we provide. The company holds a Beta of 0.37, which implies possible diversification benefits within a given portfolio. As returns on the market increase, Ocean Biomedical's returns are expected to increase less than the market. However, during the bear market, the loss of holding Ocean Biomedical is expected to be smaller as well. At this point, Ocean Biomedical has a negative expected return of -0.29%. Please make sure to check Ocean Biomedical's value at risk, accumulation distribution, and the relationship between the treynor ratio and skewness , to decide if Ocean Biomedical performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.28 |
Poor predictability
Ocean Biomedical has poor predictability. Overlapping area represents the amount of predictability between Ocean Biomedical time series from 26th of October 2024 to 10th of November 2024 and 10th of November 2024 to 25th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Ocean Biomedical price movement. The serial correlation of 0.28 indicates that nearly 28.0% of current Ocean Biomedical price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.28 | |
| Spearman Rank Test | 0.35 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Ocean Biomedical lagged returns against current returns
Autocorrelation, which is Ocean Biomedical stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Ocean Biomedical's stock expected returns. We can calculate the autocorrelation of Ocean Biomedical returns to help us make a trade decision. For example, suppose you find that Ocean Biomedical has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Ocean Biomedical regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Ocean Biomedical stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Ocean Biomedical stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Ocean Biomedical stock over time.
Current vs Lagged Prices |
| Timeline |
Ocean Biomedical Lagged Returns
When evaluating Ocean Biomedical's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Ocean Biomedical stock have on its future price. Ocean Biomedical autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Ocean Biomedical autocorrelation shows the relationship between Ocean Biomedical stock current value and its past values and can show if there is a momentum factor associated with investing in Ocean Biomedical.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Ocean Biomedical is a strong investment it is important to analyze Ocean Biomedical's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Ocean Biomedical's future performance. For an informed investment choice regarding Ocean Stock, refer to the following important reports:Check out Ocean Biomedical Correlation, Ocean Biomedical Volatility and Ocean Biomedical Alpha and Beta module to complement your research on Ocean Biomedical. For information on how to trade Ocean Stock refer to our How to Trade Ocean Stock guide.You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Ocean Biomedical technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.